{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:37:31Z","timestamp":1694630251601},"reference-count":3,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JOP"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1200\/jop.0753501","type":"journal-article","created":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T23:28:12Z","timestamp":1189726092000},"page":"248-253","source":"Crossref","is-referenced-by-count":2,"title":["Erythropoiesis- Stimulating Agents: Continued Challenges"],"prefix":"10.1200","volume":"3","member":"233","reference":[{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.150"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14567-9"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.1514"}],"container-title":["Journal of Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JOP.0753501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:29:37Z","timestamp":1653524977000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JOP.0753501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1200\/JOP.0753501"],"URL":"https:\/\/doi.org\/10.1200\/jop.0753501","relation":{},"ISSN":["1554-7477","1935-469X"],"issn-type":[{"value":"1554-7477","type":"print"},{"value":"1935-469X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}